Navigation Links
CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
Date:6/26/2008

roenteritis regardless of the infecting serotype(s).

Rotavirus infects virtually every child worldwide by age five and is the leading cause of severe gastroenteritis in infants and young children in the U.S. and worldwide. Severe, dehydrating gastroenteritis can occur as young as three months of age.

Clinical data published on two oral doses of ROTARIX show that protection was sustained through the first two years of life and ROTARIX was highly efficacious against rotavirus hospitalizations (96%) and severe rotavirus gastroenteritis (90%). Additionally, in a European phase III study, 90 percent efficacy against RGE of any severity was observed immediately following dose one and prior to the second dose. The protection offered by the two-dose schedule of ROTARIX, observed as early as after dose one, is particularly relevant as severe dehydrating rotavirus gastroenteritis can occur as young as three months of age.

In clinical studies, ROTARIX demonstrated significant and sustained efficacy through two rotavirus seasons against severe rotavirus gastroenteritis caused by types G1 (96%), G2 (86%), G3 (94%), G4 (95%), and G9 (85%), the most common circulating rotavirus types in the U.S.

ROTARIX is licensed in more than 100 countries around the world. More than 25 million doses of ROTARIX have been distributed worldwide. The U.S. FDA's approval of ROTARIX was based on one of the largest clinical development plans undertaken by a vaccine manufacturer and includes data from nearly 75,000 infants.

In clinical studies, common adverse events were fussiness/irritability, cough/runny nose, fever, loss of appetite, and vomiting. History of uncorrected congenital malformation of the gastrointestinal tract is a contraindication. Previous hypersensitivity to any component of ROTARIX, including latex rubber, should be reviewed prior to administration. Administration in infants suffering from acute diarrhea or vomiting should be delayed. Safety and ef
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
2. U.S. FDA Licenses DAPTACEL(R) Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series
3. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
4. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
5. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
6. BioLife Solutions Expands Scientific Advisory Board
7. Genstar Names Michael Hurt to Its Strategic Advisory Board
8. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
9. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
10. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
11. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... presentation to investors on Tuesday, July 29, 2014, ... presentation will include an overview of Asterias, business ... webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 ...
(Date:7/24/2014)... Yet, scientists are making progress in devising suitable ... approach relies on quantum dotsa kind of artificial ... A new study demonstrates that changing the coupling ... electrical impulses can help better control them. This ... as quantum information units, which would produce faster ...
(Date:7/24/2014)... Research and Markets has announced ... Analytical Instruments Market 2014-2018" report to their offering. ... Genomics is the study of the gene and its ... and functions of proteomes or sets of proteins by ... involves the mapping of genes and DNA sequencing to ...
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... Potential Future Application of Stem Cells as a ... Treatment for Diabetes ... Nature Biotechnology, SAN DIEGO, Feb. 20 Novocell, Inc., a stem cell,engineering ... cells can be turned into pancreatic cells,capable of producing insulin in mice. The ...
... PPD, Inc. (Nasdaq:,PPDI) today announced its plans to begin ... common stock may be purchased from time to time,in the ... a share repurchase program in,view of the current price at ... balance sheet and its ability to generate cash,as well as ...
... Rotarix Would be the Only Vaccine Indicated to Prevent, ... Circulating Types, Offering, Completion of the Vaccination by ... GAITHERSBURG, Md. and PHILADELPHIA, Feb. 20 ,GlaxoSmithKline (NYSE: ... Drug,Administration,s (FDA) Vaccines and Related Biological Products Advisory,Committee (VRBPAC) ...
Cached Biology Technology:Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 2Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 3PPD Announces Plan to Repurchase Shares of its Common Stock 2GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 2GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 3GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 4
(Date:7/25/2014)... scientists from 25 countries and 35 states will ... the Genetics Society of America (GSA) next week ... conference will feature close to 500 presentations (including ... including gene expression and regulation, functional genomics, chemical ... and a variety of diseases. , Of ...
(Date:7/25/2014)... pleiotropic factor characterized by the existence of numerous ... confer to the protein deeply different characteristics. NRG1 ... occurring during development and the different phases occurring ... axon regrowth, remyelination and target reinnervation, Researchers at ... the soluble NRG1 upregulation observed in Schwann cells ...
(Date:7/25/2014)... KANSAS CITY, MOResearchers at the Stowers Institute for ... classes of pheromone receptors, and found pheromones crucial to ... one class of receptors helps a male mouse detect ... other class of receptors lets him know if the ... sets of pheromones are critical to trigger mating. Stowers, ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2It takes two to court 2It takes two to court 3
... loss of dopamine neurons is a hallmark of many ... Stem cell biology and regenerative medicine offer novel therapies ... the online open-access journal PLoS Biology Dr. Raja Kittappa, ... McKay show that the transcription factor FOXA2 plays a ...
... invasive plant species is complex, to say the least. ... create conditions that promote population explosions of invasive plants, ... to the ecosystems they inhabit. On the other, fire ... growth. A new general technical report published by ...
... New microscopic pictures show the first-ever physical evidence ... (CF) disease. Researchers at the University of Alabama ... protein called epithelial sodium channel, or ENaC. Both proteins ... exactly what role each plays is unclear. ...
Cached Biology News:Cystic fibrosis proteins photographed interacting 2
Handy 100V Power Supply is Low-cost, compact and lightweight. Easy to operate - either 50 or 100 VDC is selectable as the output voltage. These voltages are sufficient for ordinary electrophoresis....
Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
...
BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....
Biology Products: